Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 38.24 percent increase over losses of $(0.34) per share from the same period last year.
Petros Pharmaceuticals Q2 EPS $(0.22), Sales $2.46M
Petros Pharmaceuticals (NASDAQ:PTPI) reported quarterly losses of $(0.22) per share. The company reported $2.46 million in sales this quarter.
